Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.60 |
| ▸ | F7 | P08709 | 6/20 | 0.60 |
| ▸ | F3 | P13726 | 6/20 | 0.60 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.60 |
| ▸ | PPARG | P37231 | 5/20 | 0.60 |
| ▸ | MAPT | P10636 | 4/20 | 0.60 |
| ▸ | OXER1 | Q8TDS5 | 4/20 | 0.60 |
| ▸ | PPARD | Q03181 | 4/20 | 0.60 |
| ▸ | PPARA | Q07869 | 4/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.60 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3213389 | 1.00 | ALDH1A1 (0.60) | ALDH1A1F7F3CYP19A1PPARG | |
| SCHEMBL20553455 | 1.00 | ALDH1A1 (0.60) | ALDH1A1F7F3CYP19A1PPARG | |
| SCHEMBL2984576 | 1.00 | ALDH1A1 (0.60) | ALDH1A1F7F3CYP19A1PPARG | |
| SCHEMBL20553456 | 1.00 | ALDH1A1 (0.60) | ALDH1A1F7F3CYP19A1PPARG | |
| SCHEMBL22635677 | 1.00 | ALDH1A1 (0.60) | ALDH1A1F7F3CYP19A1PPARG | |
| SCHEMBL2984578 | 1.00 | ALDH1A1 (0.60) | ALDH1A1F7F3CYP19A1PPARG | |
| SCHEMBL3224652 | 0.98 | ALDH1A1 (0.57) | ALDH1A1F7F3CYP19A1PPARG | |
| SCHEMBL15463523 | 0.95 | F7 (0.51) | ALDH1A1F7F3CYP19A1PPARG | |
| SCHEMBL4308676 | 0.95 | F7 (0.51) | ALDH1A1F7F3CYP19A1PPARG | |
| SCHEMBL4308674 | 0.95 | F7 (0.51) | ALDH1A1F7F3CYP19A1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091047-A1 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | NATIVE CODE BIO LLC (US) | 2026-04-02 | — | — | US | claimed |
| EP-4583856-A2 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | Native Code Bio, LLC (US) | 2025-07-16 | — | — | EP | claimed |
| WO-2024054688-A2 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | NATIVE CODE BIO, LLC (US) | 2024-03-14 | — | — | WO | claimed |
| CN-109971807-B | Method for synthesizing polyunsaturated fatty acid starch ester by subcritical fluid system and application thereof | 吉林省长德健康产业有限公司 | 2023-02-07 | — | — | CN | claimed |
| CN-109824719-B | Preparation method of phenylsulfonic-modified SBA-15 composite material and application of phenylsulfonic-modified SBA-15 composite material in synthesis of structured phospholipid | 大连工业大学 | 2021-07-06 | — | — | CN | claimed |
| CN-109879905-B | Preparation method of naphthyl sulfonic group modified SBA-15 and application of naphthyl sulfonic group modified SBA-15 in synthesis of phospholipid rich in unsaturated fatty acid structure | 大连工业大学 | 2021-07-06 | — | — | CN | claimed |
| EP-3011041-B1 | BIODIESEL COMPOSITION AND RELATED PROCESS AND PRODUCTS | ARGENT ENERGY UK LTD (GB) | 2020-02-19 | — | — | EP | claimed |
| EP-1478335-B1 | PERFUME CONTAINING SURFACTANT COMPOSITIONS HAVING PERFUME BURST WHEN DILUTED AND PROCESS THEREOF | UNILEVER PLC (GB) | 2014-07-30 | — | — | EP | claimed |
| EP-2061455-B1 | STABILIZED SYNTHETIC BROOD PHEROMONE FOR MANIPULATING THE BEHAVIOUR AND PHYSIOLOGY OF HONEY BEES | CONTECH ENTPR INC (CA) | 2013-07-17 | — | — | EP | claimed |
| EP-1584659-B1 | Curable silicone composition | DOW CORNING TORAY CO LTD (JP) | 2008-07-09 | — | — | EP | claimed |
| EP-1127916-B1 | Filler/adhesive agent for display units containing a curable silicone composition | DOW CORNING TORAY SILICONE (JP) | 2004-09-22 | — | — | EP | claimed |
| EP-0592577-B1 | ANTI-OVIPOSITION COMPOSITIONS INCLUDING A FATTY ACID AND/OR A FATTY ACID ALKYL ESTER AND OPTIONALLY A MONOTERPENE | AGRONOMIQUE INST NAT RECH (FR) | 1995-10-11 | — | — | EP | claimed |
| EP-0431942-B1 | Percutaneously absorbable pharmaceutical preparation containing dopamine derivative | SANSHO CO (JP) | 1994-03-23 | — | — | EP | claimed |
| US-20260091047-A1 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | NATIVE CODE BIO LLC (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4665318-A2 | THERAPEUTIC COMBINATIONS FOR INFLAMMATORY CONDITIONS AND DISORDERS | Native Code Bio, LLC (US) | 2025-12-24 | — | — | EP | disclosed |
| EP-4583856-A2 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | Native Code Bio, LLC (US) | 2025-07-16 | — | — | EP | disclosed |
| EP-1723098-A1 | METHOD FOR THE FUNCTIONALIZATION OF CONJUGATED OR CONJUGATABLE DERIVATIVES ASSISTED BY A TEMPO-TYPE ELECTROPHORIC MEDIATOR | Centre National De La Recherche Scientifique-CNRS (FR) | 2006-11-22 | — | — | EP | disclosed |
| WO-2006002867-A1 | PRODUCT FOR USE IN PAPERMAKING AND PREPARATION THEREOF | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-01-12 | — | — | WO | disclosed |
| WO-2005097726-A1 | METHOD FOR THE FUNCTIONALIZATION OF CONJUGATED OR CONJUGATABLE DERIVATIVES ASSISTED BY A TEMPO-TYPE ELECTROPHORIC MEDIATOR | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE- CNRS (FR) | 2005-10-20 | — | — | WO | disclosed |
| CN-85104633-A | Influence compound and the preparation method of composition and the purposes of plant-growth and output | — | 1987-04-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091047-A1 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | HMBS, SNCA, PYGB | ALDH1A1 4409/4885F7 2983/4885F3 4159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.